A federal appeals court on Wednesday ruled that a Washington, D.C., law that allows the district to control prescription drug prices violates federal patent law, the Washington Post reports (Leonnig, Washington Post, 8/3). The legislation, sponsored by D.C. [click link for full article]
More...